SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Research analysts at Raymond James raised their FY2024 EPS estimates for SNC-Lavalin Group in a research note issued on Wednesday, February 19th. Raymond James analyst F. Bastien now anticipates that the company will post earnings per share of $2.10 for the year, up from their previous estimate of $1.56. Raymond James also issued estimates for SNC-Lavalin Group’s Q4 2024 earnings at $0.59 EPS.
Separately, Stifel Canada upgraded SNC-Lavalin Group to a “strong-buy” rating in a research report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
About SNC-Lavalin Group
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Articles
- Five stocks we like better than SNC-Lavalin Group
- Differences Between Momentum Investing and Long Term Investing
- These 3 Defensive Retail Stocks Are Outpacing the Market
- Ride Out The Recession With These Dividend Kings
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Do ETFs Pay Dividends? What You Need to Know
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
